Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Linzess price, strengths & recalls

Brand of linaclotide (generic)

Pharmacies pay $270.56 for 30 capsules of Linzess 0.145 mg capsule this week, and from $270.30 to $270.56 across its 3 priced strengths and forms. It has 1 recall on record, none ongoing. Its official label last changed on October 19, 2026.

Medicare price 2027Brand
Pharmacies pay$270.56for 30 capsules of 0.145 mg capsuleNo change in 4 weeks
Fair cash price
$321.64
Strengths
3
Makers
1
Updated
Nov 11

Linzess price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.072 mg capsule Brand$9.01$270.30 / 30 capsulesNo change-50.3%
0.145 mg capsule Brand$9.02$270.56 / 30 capsulesNo change-50.3%
0.29 mg capsule Brand$9.01$270.42 / 30 capsulesNo change-50.3%

The lowest cost per capsule is 0.072 mg capsule at $9.01. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Linzess vs generic linaclotide

There is no generic version of Linzess on the market yet. Its last listed patent or exclusivity runs to February 16, 2034 - generics often follow, though court cases and settlements can move the date either way.

GenericLinaclotide prices

Medicare negotiated price

$539.00$136.00-75%

Medicare negotiated a maximum fair price of $136.00 for a 30-day supply of Linzess, against a 2024 list price of $539.00. It takes effect on January 1, 2027.

What this means for patients

  • The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
  • What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
  • Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
  • If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Every Medicare negotiated price

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls1 recall on record, latest Jun 2, 2021

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for linzess? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedOctober 19, 2026
Version40 of 29
EffectiveOct 9, 2026
Read the label

These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS. LINZESS® (linaclotide) capsules, for oral useInitial U.S. Approval: 2012

This drug has a boxed warning

WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE

LINZESS is contraindicated in patients less than 2 years of age; in nonclinical studies in neonatal mice, administration of a single, clinically relevant adult oral dose of linaclotide caused deaths due to dehydration [see Contraindications (4), Warnings and Precautions (5.1), Use in Specific Populations (8.4)].

WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE

See full prescribing information for complete boxed warning.

LINZESS is contraindicated in patients less than 2 years of age; in neonatal mice, linaclotide caused deaths due to dehydration. (4, 5.1, 8.4)

Recent major changes (as listed on the label)

Indications and Usage (1) | 5/2026 |

Dosage and Administration, Recommended Dosage (2.1) | 5/2026 |

Warnings and Precautions, Diarrhea (5.2) | 5/2026 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA202811 · Abbvie
First approved
August 30, 2012 (14 years ago)
Latest approved change
May 21, 2026
Approved label
PDF, May 26, 2026
Generic makers
None on the market
Last patent listed
February 16, 2034
Exclusivity ends
May 21, 2029

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Linzess questions

How much does linzess cost without insurance?

Pharmacies pay about $270.56 for 30 capsules of linzess 0.145 mg capsule ($9.02 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $321.64. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Linzess?

Yes: linaclotide. Compare linaclotide prices.

Is linzess in shortage?

No shortage is reported for linzess right now. We check the national shortage list every day.

Has linzess been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the linzess label last change?

The official label was last updated on October 19, 2026 (version 40). See what changed.

Does Medicare have a negotiated price for Linzess?

Yes: $136.00 for a 30-day supply of Linzess, from January 1, 2027. What you pay still depends on your plan.

Talk about linzess

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.